In a research targeting HER2 receptors over-expressed on tumor cell membranes, E. coli MVs in mice with high specificity and weaken tumor load was designed to carry anti-tumor siRNAs and express HER2 ligands to target tumors (Gujrati et al., 2014). The gene discussed is ERBB2; the disease is neoplasm.